Choksi Laboratories Surges 21.6% on Strong Earnings Momentum

Choksi Laboratories Limited (CHOKSILA.BO) delivered a powerful rally on the BSE, surging 21.6% to close at ₹120.4 on May 20, 2026. The specialty testing services company’s sharp gain reflects strong investor confidence ahead of earnings scheduled for May 27. With a market cap of ₹746 crore and trading volume jumping to 34,012 shares, CHOKSILA.BO stock has captured market attention. The stock now trades above its 50-day average of ₹100.82, signaling positive momentum in the analytical testing sector.

CHOKSILA.BO Stock Price Performance Today

Choksi Laboratories Limited stock opened at ₹105.3 and climbed to a day high of ₹124.5, delivering a ₹21.4 gain from the previous close of ₹99. The 21.6% jump marks one of the strongest single-day moves for the Indore-based testing company. Trading volume surged to 34,012 shares, nearly 8 times the average daily volume of 4,174 shares, indicating strong institutional and retail participation.

The stock’s momentum reflects anticipation around the company’s earnings announcement scheduled for May 27. Choksi Laboratories trades above its 50-day moving average of ₹100.82 and 200-day average of ₹140.83, though it remains below its 52-week high of ₹236.7. The current price action suggests renewed interest in the specialty business services sector, where analytical testing plays a critical role across pharmaceuticals, food, and construction materials.

Financial Metrics and Valuation

CHOKSILA.BO trades at a P/E ratio of 39.96 with earnings per share (EPS) of ₹2.68, reflecting investor expectations for future growth. The price-to-sales ratio stands at 1.67, while the price-to-book ratio is 3.05, indicating the stock commands a premium to its tangible assets. Market cap of ₹746 crore positions Choksi Laboratories as a mid-cap player in the industrials sector.

The company’s gross profit margin of 68.3% demonstrates strong pricing power in its testing services. However, the net profit margin of 4.2% reflects operational challenges and high tax burden at 44.6%. Return on equity (ROE) of 7.85% and return on assets (ROA) of 2.85% suggest moderate efficiency in deploying shareholder capital. Track CHOKSILA.BO on Meyka for real-time updates on these key metrics.

Meyka AI Stock Grade and Analyst Outlook

Meyka AI rates CHOKSILA.BO with a grade of B and a Hold recommendation. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The rating reflects mixed signals: the company’s strong gross margins and market position are offset by weak profitability and elevated debt levels.

The company carries a debt-to-equity ratio of 1.20, indicating moderate leverage. Interest coverage of 1.91x suggests limited cushion for debt servicing. These grades are not guaranteed and we are not financial advisors. Investors should conduct thorough due diligence before making investment decisions based on this analysis.

Choksi Laboratories Limited Price Forecast

Meyka AI’s forecast model projects CHOKSILA.BO reaching ₹206.4 within 12 months, implying 71.2% upside from current levels. The three-year forecast stands at ₹317.1, while the five-year target reaches ₹427.3. These projections assume continued growth in analytical testing demand across pharmaceuticals and food safety sectors.

The forecast reflects the company’s established market position since its 1982 founding and BSE listing in 2002. With 349 full-time employees and headquarters in Indore, Choksi Laboratories serves a diversified client base. However, investors should note the company’s current debt burden and modest profitability may constrain near-term growth. The forecast remains subject to market conditions, regulatory changes, and sector dynamics.

Final Thoughts

Choksi Laboratories Limited’s 21.6% surge reflects strong pre-earnings momentum and renewed investor confidence in the specialty testing sector. The stock’s jump to ₹120.4 on elevated trading volume signals institutional buying ahead of May 27 earnings. While Meyka AI’s B-grade rating suggests a Hold stance, the company’s strong gross margins and market position offer long-term appeal. Investors should monitor earnings results and debt management closely before increasing exposure to CHOKSILA.BO stock.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.